Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites

BACKGROUND: Tamoxifen has dramatically reduced the recurrence and mortality rate of estrogen receptor positive breast cancer. However, the efficacy of tamoxifen varies between individuals and 40% of patients will have a recurrence despite adjuvant tamoxifen treatment. Factors that predict tamoxifen...

Descripción completa

Detalles Bibliográficos
Autores principales: Jager, Nynke GL, Koornstra, Rutger HT, Vincent, Andrew D, van Schaik, Ron HN, Huitema, Alwin DR, Korse, Tiny M, Schellens, Jan HM, Linn, Sabine C, Beijnen, Jos H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880169/
https://www.ncbi.nlm.nih.gov/pubmed/24373320
http://dx.doi.org/10.1186/1471-2407-13-612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880169/
https://www.ncbi.nlm.nih.gov/pubmed/24373320
http://dx.doi.org/10.1186/1471-2407-13-612

Ejemplares similares